NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Assaf-Harofeh Medical Center
Conditions: COVID-19
Interventions: COVID-19 RT-PCR, COVID-19 Serology, Symptoms questionnare
Countries: Israel
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The measures in which public health officials quarantine confirmed and isolate symptomatic cases in order to reduce the spread COVID-19 is the common practice used in most countries. However, a significant question remains in regards to the asymptomatically infected individuals, which may propagate the virus and impede infection control. The other question to consider is whether these asymptomatic carriers develop an immune response or continue viral shedding. The purpose of the current study is the evaluate the immune response, i.e developing anti-SARS-CoV-2 antibodies in the asymptomatic cases, in a household study design. We plan to evaluate over 1000 patients with positive COVID-19 results and their households.
Sex: ALL
Age: 18 Years to —
Study type: OBSERVATIONAL
Inclusion Criteria: * Positive COVID-19 RT-PCR to the subject or his/her household. * Over 18 years old * Ability to sign an informed consent Exclusion Criteria: * Inability to sign an informed consent * Pregnancy
- Ramla, Israel